Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr;37(4):e14904.
doi: 10.1111/ctr.14904. Epub 2023 Feb 7.

Outcomes of heart transplant recipients bridged with percutaneous versus durable left ventricular assist devices

Yu Xia  1 , Juka S Kim  1 , Isabel K Eng  1 , Ali Nsair  2 , Abbas Ardehali  1 , Richard J Shemin  1 , Murray H Kwon  1
Affiliations

Outcomes of heart transplant recipients bridged with percutaneous versus durable left ventricular assist devices

Yu Xia et al. Clin Transplant. 2023 Apr.

Abstract

Background: The new United Network for Organ Sharing (UNOS) heart allocation policy prioritizes temporary percutaneous over durable left ventricular assist devices (LVAD) as bridge to transplant. We sought to examine 1-year outcomes of heart transplant recipients bridged with Impella versus durable LVADs.

Methods: All primary adult orthotopic heart transplant recipients registered in UNOS between January 2016 and June 2021 were analyzed. Recipients were identified as being bridged with isolated durable or percutaneous LVAD at the time of transplant. Baseline characteristics were compared and 1-year survival was examined using the Kaplan Meier method and multivariable Cox proportional hazards regression.

Results: During our study period, heart transplant recipients bridged with LVADs were divided between 5422(94%) durable and 324(6%) percutaneous options. Impella-bridged recipients were more likely to be status 1A under the old allocation system (98% vs. 70%, p < .01) and status 2 or higher under the new allocation system (99% vs. 24%, p < .01). Impella-bridged recipients were less likely to be obese (27% vs. 42%, p < .01), have ischemic cardiomyopathy (27% vs. 34%, p < .01), and were more likely to be on inotropic agents at the time of transplant (68% vs. 6%, p < .01). One-year post-transplant survival was not significantly different between the two groups on univariable (HR .87, 95% CI .56-1.37) or multivariable analysis (aHR .63, 95% CI .37-1.07).

Conclusions: Following the UNOS allocation policy change, Impella utilization has increased with no significant difference in 1-year survival compared to bridge with durable LVADs. Impella may be a reasonable alternative to durable LVADs in select patients.

Keywords: Impella; LVAD; heart transplant.

PubMed Disclaimer

References

REFERENCES

    1. Suarez-Pierre A, Zhou X, Fraser CD, et al. Survival and functional status after bridge-to-transplant with a left ventricular assist device. ASAIO J. 2019;65(7):661-667. doi: 10.1097/MAT.0000000000000874
    1. Jawitz OK, Fudim M, Raman V, et al. Renal outcomes in patients bridged to heart transplant with a left ventricular assist device. Ann Thoracic Surg. 2020;110(2):567-574. doi: 10.1016/j.athoracsur.2019.11.021
    1. Chung JS, Emerson D, Ramzy D, et al. A new paradigm in mechanical circulatory support: 100-patient experience. Ann Thoracic Surg. 2020;109(5):1370-1377. doi: 10.1016/j.athoracsur.2019.08.041
    1. Marbach JA, Chweich H, Miyashita S, Kapur NK. Temporary mechanical circulatory support devices: updates from recent studies. Curr Opin Cardiol. 2021;36(4):375-383. doi: 10.1097/HCO.0000000000000880
    1. Ancona MB, Montorfano M, Masiero G, et al. Device-related complications after Impella mechanical circulatory support implantation: an IMP-IT observational multicentre registry substudy. Eur Heart J Acute Cardiovasc Care. 2021 Dec 6;10(9):999-1006. doi: 10.1093/ehjacc/zuab051

Publication types

LinkOut - more resources